ABCG2 and B-cell non-Hodgkin lymphoma: In previous studies, rs1481012 in ABCG2 has been associated with risk of hyperuricemia, gout, coronary artery disease (CAD), B-cell non-Hodgkin lymphoma (B-NHL), and chronic lymphocytic leukemia (CLL) [28–30].